Thyroid Nodules: Symptoms, Causes, Diagnosis, and Treatment

What is Thyroid Nodules?

The thyroid is a butterfly-shaped gland located at the front of the neck, just below the larynx (voice box). It produces two key hormones:

• Triiodothyronine (T3)
• Thyroxine (T4)

T3 and T4 are secreted into the bloodstream and transported throughout the body, where they help to:

• Regulate metabolism, which is the way the body uses and stores energy.
• Maintain normal body temperature.
• Support the proper functioning of the heart, brain, muscles, and other organs

Thyroid nodules are solid or fluid-filled masses that form within the thyroid gland. They are clinically significant for several reasons. First, they can cause thyroid dysfunction. Second, they occasionally produce symptoms related to compression of surrounding structures, such as the trachea and esophagus. Most importantly, however, they carry a small but meaningful risk of malignancy and may potentially evolve into thyroid cancer.

The vast majority of thyroid nodules, however, are not dangerous and do not cause symptoms. The prevalence of malignancy in thyroid nodules assessed by biopsy ranges from 4.0% to 6.5%, and this risk is independent of nodule size.

Thyroid nodules are more common in women and in the elderly. They are often discovered incidentally during a routine medical examination. Some, however, can grow large enough to be visible to the naked eye and may interfere with swallowing or breathing.

The primary goal of thyroid nodule evaluation is to identify which nodules are malignant and require treatment. Therapeutic options depend on the type of nodule found, and surgical removal is the preferred approach for dangerous lesions.

Prevention tip: The most effective strategy for preventing thyroid nodules is iodine prophylaxis. This means ensuring adequate iodine intake, which can be easily achieved through regular consumption of iodized salt.

---

Causes

A thyroid nodule is a proliferation of glandular tissue or a fluid-filled cyst forming a mass within the thyroid gland.

Nodules are extremely common, and the likelihood of developing them increases with age. It is estimated that approximately one in two individuals over the age of 60 has at least one thyroid nodule. Although they generally do not cause symptoms, a large nodule can occasionally cause pain, hoarseness, or difficulty with swallowing or breathing.

The primary medical concern related to thyroid nodules is their occasional malignant nature. Thyroid cancer is found in approximately 8% of nodules in males and 4% in females. This means that more than 90% of all thyroid nodules are benign (non-cancerous).

Known and Possible Causes

• Iodine deficiency: A common dietary cause that predisposes to goiter formation and nodule development. Iodine deficiency remains a major public health issue in certain regions of the world.

• Overgrowth of normal thyroid tissue (thyroid adenoma): The reason for this localized growth is often unclear. Thyroid adenomas are benign and are not typically considered dangerous unless they cause symptoms related to their size or produce excess hormones.

• Thyroid cysts: Cystic cavities (fluid-filled formations) develop most often as a result of degenerative changes in thyroid adenomas. They may be simple cysts or complex (mixed solid and cystic).

• Chronic thyroid inflammation (thyroiditis): Hashimoto’s thyroiditis, the most common cause of hypothyroidism, is an autoimmune condition. It causes chronic inflammation of the thyroid and may lead to nodular growth within the gland.

• Family history: A familial predisposition to thyroid nodules and thyroid cancer has been observed, suggesting a genetic component in some cases.

• Radiation exposure: Previous radiation therapy to the head or neck area is a well-established risk factor for thyroid nodule formation and thyroid cancer.

• Female sex and hormonal factors: Women are significantly more likely to develop thyroid nodules than men, suggesting a role for estrogen and other sex hormones in their pathogenesis.

---

Hot Nodules and Cold Nodules

One of the most clinically useful distinctions in thyroid nodule assessment is between “hot” and “cold” nodules. This classification is determined through thyroid scintigraphy, an imaging technique that evaluates how much radioactive iodine the gland and its nodules absorb.

Hot Nodules

• Generally benign
• Exhibit high iodine uptake (they actively absorb available iodine) and produce thyroid hormones
• Unlike normal glandular tissue, hot nodules may produce thyroid hormones independently of the body’s regulatory mechanisms (TSH), potentially leading to hyperthyroidism
• Account for approximately 5% of all thyroid nodules

Cold Nodules

• The most common type, representing approximately 95% of all thyroid nodules.
• Show reduced or absent iodine uptake, reflecting abnormal cellular function.
• Require greater caution, as the minority of malignant thyroid nodules fall into this category.
• However, only about 5% of cold nodules are actually cancerous. The vast majority are benign cysts, adenomas, or areas of inflammation.

Key takeaway: While cold nodules are more numerous and carry a slightly higher relative risk of malignancy, most cold nodules are still benign. Further evaluation with ultrasound and biopsy is essential to characterize them accurately.

---

Symptoms

The majority of thyroid nodules cause no signs or symptoms and are discovered incidentally during routine check-ups or investigations performed for unrelated conditions.

Symptoms Related to Nodule Size

In some cases, nodules may grow large enough to:

• Become visible externally at the base of the neck (as a visible swelling or goiter).
• Be felt on palpation of the neck.
• Compress the airway or esophagus, causing a sensation of pressure in the throat, shortness of breath, or difficulty swallowing.

Symptoms Related to Hormonal Activity (Hot Nodules)

Some nodules, particularly the so-called “hot” ones, produce excessive amounts of thyroxine. This overproduction leads to symptoms of hyperthyroidism.

• Unexplained weight loss
• Mood changes and emotional instability
• Difficulty sleeping (insomnia)
• Fatigue
• Heat intolerance
• Tremor
• Nervousness
• Anxiety
• Irritability
• Rapid or irregular heartbeat (palpitations/arrhythmia)

Symptoms Suggesting Malignancy

Rarely, thyroid nodules may cause hoarseness. This symptom is more commonly linked to malignant nodules, though it can occur in other cases as well. For more details, see hoarseness. Most malignant thyroid nodules grow slowly and may be small when detected. Aggressive thyroid cancers are rare but may present as large, solid, fixed masses with rapid growth.

Important: It is not possible to determine whether a nodule is malignant based on symptoms alone. Medical evaluation and appropriate investigations are always required.

---

When to Call a Doctor

Although most thyroid nodules are benign and do not cause problems, it is essential to have any unusual swelling in the neck evaluated by a physician, especially if associated with problems swallowing or breathing, as the possibility of cancer must be considered.

Consult a Doctor if You Notice:

Possible nodule-related signs:

• Hoarseness that persists for more than one month
• Difficulty swallowing

Symptoms suggestive of hyperthyroidism:

• Sudden weight loss despite a normal or increased appetite
• Palpitations or racing heartbeat
• Unusual fatigue or weakness
• Sleep disturbances
• Muscle weakness
• Nervousness or irritability
• New or worsening anxiety

Do not delay: Even if you feel well, a new or growing lump in the neck should always be assessed promptly. Early evaluation is key to ruling out malignancy and guiding appropriate management.

---

Complications

Most thyroid nodules do not lead to serious complications. However, the following may occur:

Compressive Symptoms

Larger nodules or a multinodular goiter (an enlarged thyroid gland containing multiple distinct nodules) can interfere with swallowing or breathing, particularly during sleep or physical exertion.

Hyperthyroidism

An overactive (“hot”) nodule may cause hyperthyroidism, with symptoms including weight loss, palpitations, heat intolerance, tremor, and anxiety. If untreated, hyperthyroidism can increase the risk of atrial fibrillation, osteoporosis, and other serious complications.

Thyroid Cancer

Although rare (affecting fewer than 5–8% of all thyroid nodules), malignant transformation represents the most serious potential complication of thyroid nodules. Most thyroid cancers, especially papillary thyroid carcinoma (the most common type), have an excellent prognosis when detected early.

---

Diagnosis

Most thyroid nodules are discovered during a routine physical examination of the neck. Following this finding, the physician will order a series of investigations to characterize the nodule and assess thyroid function.

Blood Tests

The most commonly ordered blood tests to evaluate thyroid function include:

• TSH (Thyroid-Stimulating Hormone): The primary screening test. A suppressed TSH suggests a hyperactive (“hot”) nodule; an elevated TSH may indicate hypothyroidism or Hashimoto’s thyroiditis.
• Free T3 and Free T4: To assess actual circulating thyroid hormone levels.
• Anti-thyroid antibodies (anti-TPO, anti-thyroglobulin): To evaluate for autoimmune thyroid disease (e.g., Hashimoto’s thyroiditis).
• Calcitonin: In selected cases, to screen for medullary thyroid carcinoma.
• Thyroglobulin: Used as a tumor marker after thyroid surgery or radioiodine treatment.

Blood tests alone cannot exclude thyroid cancer. Imaging and, if indicated, biopsy are always necessary for a complete evaluation.

Ultrasound

Thyroid ultrasound is the gold-standard first-line imaging modality and is used to:

• Obtain a precise morphological picture of the gland’s size, shape, and structure
• Determine whether a nodule is solid or fluid-filled (cystic). Pure cysts are rarely malignant.
• Measure the exact dimensions of the nodule.
• Detect non-palpable nodules that cannot be felt on physical examination.
• Identify suspicious ultrasound features that increase the probability of malignancy, including:
  • Hypoechogenicity (appears darker than surrounding tissue).
  • Microcalcifications.
  • Irregular or poorly defined margins.
  • Taller-than-wide shape.
  • Increased internal vascularity.

Ultrasound is completely painless and does not use radiation. It is also the preferred tool for guiding needle placement during fine-needle aspiration biopsy (ultrasound-guided FNAB).

Several risk-stratification systems, including the ACR TIRADS (Thyroid Imaging Reporting and Data System), have been developed to standardize the interpretation of thyroid ultrasound findings and guide decisions about biopsy.

Thyroid Scintigraphy

Thyroid scintigraphy uses small amounts of radioactive iodine (or technetium-99m) and a specialized detector (gamma camera) to produce a functional image of the thyroid gland. This technique determines whether a nodule is:

• Hyperfunctioning (“hot”): absorbs more radiotracer than surrounding tissue. Generally benign, but may cause hyperthyroidism.
• Isofunctioning (“warm”): absorbs similar amounts to surrounding tissue.
• Hypofunctioning (“cold”): absorbs less radiotracer. Requires further evaluation, as a small minority are malignant.

Scintigraphy is not routinely used as a first-line investigation; ultrasound is generally preferred. However, it is particularly useful when TSH is suppressed, suggesting a hyperactive nodule, as it can confirm autonomously functioning nodules and help avoid unnecessary biopsy of hot nodules (which are almost never malignant).

Biopsy

Fine-needle aspiration biopsy (FNAB), also called fine-needle aspiration cytology (FNAC), uses a thin needle to extract cells or fluid from the nodule for cytological analysis. It is typically performed under ultrasound guidance to ensure accurate needle placement.

FNAB is the most accurate method for identifying cancerous or suspicious nodules, with a sensitivity and specificity both exceeding 90% in most studies.

Results are typically classified according to the Bethesda System for Reporting Thyroid Cytopathology into six categories:

---

Treatment

Treatment depends on the type of thyroid nodule identified through clinical and diagnostic evaluation.

Malignant or Suspicious Nodules

Experts recommend surgical removal of the thyroid (thyroidectomy) for malignant nodules or those that are highly suspicious for malignancy. Surgery may involve:

• Total thyroidectomy (removal of the entire gland) is most commonly performed for cancer.
• Hemithyroidectomy (lobectomy): removal of half the gland, typically performed for selected low-risk cases.

Following surgical removal, radioiodine (I-131) therapy may be indicated to destroy any residual thyroid cancer cells, particularly in intermediate- and high-risk cases. After a total thyroidectomy, lifelong thyroid hormone replacement therapy (levothyroxine) is required.

The prognosis for the most common type of thyroid cancer, papillary thyroid carcinoma, is excellent. When detected early, the 10-year survival rate exceeds 95%.

Benign Nodules or Nodules Too Small for Biopsy

Benign nodules confirmed on biopsy, or small nodules not yet meeting biopsy criteria, are managed with:

• Active surveillance: Ultrasound every 6–12 months, along with an annual endocrinology visit
• Repeat FNAB if the nodule shows growth (typically defined as a ≥20% increase in two or more dimensions, or ≥2 mm increase)
• Surgical removal may still be recommended for benign nodules that:
  • Continue to grow over time
  • Cause compressive symptoms (swallowing or breathing difficulties)
  • Are cosmetically concerning to the patient

Hyperfunctioning (“Hot”) Nodules

Hot nodules are almost never cancerous, but they can cause hyperthyroidism. This condition may lead to serious health consequences, such as atrial fibrillation and bone loss, if left untreated. Management options include:

• Surgical removal (lobectomy)
• Radioiodine therapy (I-131): A highly effective, minimally invasive option that selectively destroys overactive thyroid tissue
• Anti-thyroid medications (e.g., methimazole, carbimazole): Used as a temporary measure to control hyperthyroid symptoms while awaiting definitive treatment
• Percutaneous ethanol injection or radiofrequency ablation: Increasingly used as minimally invasive alternatives in selected centers

Minimally Invasive Alternatives

For selected patients who are not surgical candidates or prefer to avoid surgery, image-guided ablation techniques such as radiofrequency ablation (RFA), laser ablation, and high-intensity focused ultrasound (HIFU) are emerging as effective options. These methods can be used for benign symptomatic nodules and, in some cases, low-risk thyroid cancers. These techniques are offered in specialized centers and can significantly reduce nodule volume with low complication rates.

---

Sources and Bibliography

• Endocrine Society – Thyroid Nodules (Hormone.org)
• Thyroid Nodules – PMC/NCBI
• Haugen BR, et al. “2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer”. Thyroid. 2016;26(1):1–133. DOI: 10.1089/thy.2015.0020
• Tessler FN, et al. “ACR Thyroid Imaging, Reporting and Data System (ACR TIRADS): White Paper of the ACR TIRADS Committee”. Journal of the American College of Radiology. 2017. DOI: 10.1016/j.jacr.2017.01.046
• Cibas ES, Ali SZ. “The 2017 Bethesda System for Reporting Thyroid Cytopathology”. Thyroid. 2017;27(11):1341–1346. DOI: 10.1089/thy.2017.0500
• Durante C, et al. “The Natural History of Benign Thyroid Nodules”. JAMA. 2015;313(9):926–935. DOI: 10.1001/jama.2015.0956
• World Health Organization. Thyroid Cancer Fact Sheet. Available at: https://www.who.int/
• National Cancer Institute. Thyroid Cancer Treatment (PDQ). Available at: https://www.cancer.gov/types/thyroid
• Grani G, et al. “Ultrasonography scoring systems can predict malignancy in thyroid nodules”. Endocrine. 2017. DOI: 10.1007/s12020-016-1117-0